Provided by Tiger Trade Technology Pte. Ltd.

ArriVent BioPharma

21.43
-0.3750-1.72%
Post-market: 21.430.00000.00%16:34 EDT
Volume:421.66K
Turnover:9.13M
Market Cap:947.24M
PE:-4.96
High:22.71
Open:21.65
Low:21.30
Close:21.81
52wk High:27.22
52wk Low:15.47
Shares:44.20M
Float Shares:25.53M
Volume Ratio:0.80
T/O Rate:1.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3239
EPS(LYR):-4.3239
ROE:-58.88%
ROA:-36.49%
PB:3.08
PE(LYR):-4.96

Loading ...

Jan 22, 2025

Major Issues Report

Form 8-K - Current report
Dec 04, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 11, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 15, 2024

Major Issues Report

Form 8-K - Current report
Jul 09, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jul 09, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 22, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals